摘要
目的研制及考评肝癌患者生存质量测定量表。方法采用选题小组和议题小组的程序化决策方式制定量表，并随机抽取１０５例肝癌患者进行测定，以对量表进行考评。结果（１）躯体、心理、症状／副作用、社会功能四个领域以及量表总分的重测信度分别为：０．７６、０．９６、０．７１、０．８０和０．８４：四个领域的内部一致性系数分别为０．７８、０．８１、０．７５和０．６８；（２）量表的结构与概念构思相符，参照于ＦＬＩＣ和ＳＦ－３６两个量表的效标效度分别为０．７６和０．６５；（３）量表能敏感地反应治疗前后生存质量的变化。结论本文研制的量表具有较好的信度、效度和反应度。
Objectives To develop and evaluate a self-administered quality of life instrument for patients of liver cancer.Methods The structured group(nominal group and focus group)methods and the theory and methodology in developing rating scale was used to establish the instrument.The materials from 105 cases of patients of liver cancer in hospital were used to evaluate the instrument.Results (1) the testretest coefficients for physical,psychological,symptom/side effects,social domains and the overall scale are 0.76,0.86,0.71,0.80 and 0.84 respectively; α coefficients for above 4 domains are 0.78, 0.81,0.75 and 0 68 respectively;(2) constructs of the scale is consistent with the QOL concept,criterion validity with FLIC and SF36 are 0.76 and 0.65 respectively; (3) the scale can reflect the change of patients' QOL before and after treatments. Conclusions The instrument is of better validity,relibility and responsiveness and can be used in practice.
出处
《中国行为医学科学》
CSCD
1998年第3期170-173,共4页
Chinese Journal of Behavioral Medical Science
基金
高等学校博士点学科专项科基金
